Annals of the rheumatic diseases, 81(6):221307, 780-785. BMJ Publishing Group Annals of the Rheumatic Diseases, 81(6), 780-785. BMJ PUBLISHING GROUP Annals of the Rheumatic Diseases Annals of the Rheumatic Diseases, BMJ Publishing Group, 2022, pp.annrheumdis-2021-221307. ⟨10.1136/annrheumdis-2021-221307⟩ Annals of the rheumatic diseases (2022)
Ostergaard, M, van Vollenhoven, R, Rudin, A, Hetland, M L, Heiberg, M S, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Ørnbjerg, L, Bøyesen, P, Olsen, I, Lend, K, Hørslev-Petersen, K, Uhlig, T, Sokka-isler, T, Grondal, G, Krabbe, S, Lindqvist, J, Gjertsson, I, Glinatsi, D, Kapetanovic, M, Aga, A-B, Faustini, F, Parmanne, P, Lorenzen, T, Cagnotto, G, Back, J, Hendricks, O, Vedder, D, Rannio, T, Grenholm, E, Ljoså, M-K, Brodin, E, Lindegaard, H M, Söderbergh, A, Rizk, M, Hermansson, E, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D J, Laurberg, T B, Bakland, G, Haavardsholm, E & Lampa, J 2021, ' An Investigator-initiated Multicenter Randomized Study in Early Rheumatoid Arthritis of Active Conventional Therapy versus Three Biological Treatments: 48 Week Clinical and Radiographic Results of the NORD-STAR Trial ', ACR Convergence 2021, 03/11/2021-09/11/2021 pp. 1-6 . < https://acrabstracts.org/abstract/an-investigator-initiated-multicenter-randomized-study-in-early-rheumatoid-arthritis-of-active-conventional-therapy-versus-three-biological-treatments-48-week-clinical-and-radiographic-results-of-the/ >
Møller-Bisgaard, S, Georgiadis, S, Hørslev-Petersen, K, Ejbjerg, B J, Hetland, M L, Ornbjerg, L, Glinatski, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H M, Bliddal, H, Steen Krogh, N, Ellingsen, T, Nielsen, A, Balding, L, Jurik, A G, Thomsen, H & Østergaard, M 2020, ' PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY : Predictors of achieving stringent remission in patients with established rheumatoid arthritis in clinical remission following a treat-to-target strategy ', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, pp. 1405 . < https://ard.bmj.com/content/79/Suppl_1/1405.2 >